EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3 ‐associated activity nor glycogen production in human or mouse skeletal muscle

Nicolas O Eskesen iD, Rasmus Kjøbsted iD, Jesper Bratz Birk, Nicolai S Henriksen iD, Nicoline R Andersen, Stine Ringholm, Henriette Pilegaard, Jørgen F P Wojtaszewski

Acta Physiologica · 2024

DOI: 10.1111/apha.14213 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Physiologica, 2024. Verfasst von Nicolas O Eskesen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Exercise and Sports, August Krogh Section for Molecular Physiology, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: AMP-Activated Protein Kinases, Glycogen, Muscle, Skeletal. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

AMP‐activated protein kinase (AMPK) is activated during cellular energy perturbation. AMPK complexes are composed of three subunits and several variants of AMPK are expressed in skeletal muscle. The regulatory AMPKγ3 subunit is predominantly expressed in fast‐twitch muscle fibers. A human AMPKγ3 R225W mutation has been described. The mutation increases the total pool of AMPK activity in cells cultured from R225W carrier muscle and is associated with increased glycogen levels in mature skeletal muscle. This led to the idea of AMPKγ3 being involved in the regulation of skeletal muscle glycogen levels. Evidence for this causative link remains to be provided.

Methods

We studied muscle biopsies from human carriers of the AMPKγ3 R225W mutation and we developed a novel AMPKγ3 R225W knock‐in mouse model (KI HOM). Through in vitro, in situ, and ex vivo techniques, we investigated AMPK activity, AMPK function, and glycogen levels in skeletal muscle of humans and mice.

Results

In human carriers, the basal AMPKγ3‐associated activity was reduced when assayed in the absence of exogenous AMP. No difference was observed when assayed under AMP saturation, which was supported by findings in muscle of KI HOM mice. Furthermore, effects of AICAR/muscle contraction on AMPKγ3‐associated activity were absent in KI HOM muscle. Muscle glycogen levels were not affected by the mutation in human carriers or in KI HOM mice.

Conclusions

The AMPKγ3 R225W mutation does not impact the AMPK‐associated activity in human skeletal muscle and the mutation is not linked to glycogen accumulation. The R225W mutation ablates the AMPKγ3‐associated activation by AICAR/muscle contractions, presumably due to loss of nucleotide binding in the CBS 1 domain of AMPKγ3.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AMP-Activated Protein KinasesGlycogenMuscle, SkeletalAdultAnimalsFemaleHumansMaleMiceMiddle AgedAminoimidazole CarboxamideGene Knock-In TechniquesMutationRibonucleotides

Stichwörter der Autor:innen

AICARAMPKglycogenmuscle contractionskeletal muscle

Substanzen

AICA ribonucleotideAminoimidazole CarboxamideAMP-Activated Protein KinasesGlycogenPRKAG3 protein, humanRibonucleotidesPrkag3 protein, mouse

Autor:innen und Institutionen

  • Department of Nutrition, Exercise and Sports, August Krogh Section for Molecular Physiology, University of Copenhagen, Copenhagen, Denmark.
  • Department of Biology, Section of Cell Biology and Physiology, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Nicolas O Eskesen, Rasmus Kjøbsted, Nicolai S Henriksen

Zitieren

APA

Eskesen, N. O., Kjøbsted, R., Birk, J. B., Henriksen, N. S., Andersen, N. R., Ringholm, S., Pilegaard, H., & Wojtaszewski, J. F. P. (2024). The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3 ‐associated activity nor glycogen production in human or mouse skeletal muscle. Acta Physiologica. https://doi.org/10.1111/apha.14213

Vancouver

Eskesen NO, Kjøbsted R, Birk JB, Henriksen NS, Andersen NR, Ringholm S, et al. The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3 ‐associated activity nor glycogen production in human or mouse skeletal muscle. Acta Physiologica. 2024. doi:10.1111/apha.14213

BibTeX
@article{Eskesen2024,
  author = {Eskesen, Nicolas O and Kjøbsted, Rasmus and Birk, Jesper Bratz and Henriksen, Nicolai S and Andersen, Nicoline R and Ringholm, Stine and Pilegaard, Henriette and Wojtaszewski, Jørgen F P},
  title = {The human AMPKγ3 R225W mutation negatively impacts site‐1 nucleotide binding and does not enhance basal AMPKγ3 ‐associated activity nor glycogen production in human or mouse skeletal muscle},
  journal = {Acta Physiologica},
  year = {2024},
  doi = {10.1111/apha.14213}
}
Kostenlos starten →